Separation method of ovarian cancer related mesenchymal stem cells and application of ovarian cancer related mesenchymal stem cells in tumor resistance
Through direct tissue block isolation method and multi-step identification process, ovarian cancer-related mesenchymal stem cells were successfully isolated and identified, solving the problem of lack of consistency standards in the prior art, and providing an effective tool for drug screening and tumor research.
CN119530142AActive Publication Date: 2025-02-28BEIJING UNIV OF CHINESE MEDICINE
Patent Information
- Application Number
- CN202411763001.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-03
- Publication Date
- 2025-02-28
- Estimated Expiration
- 2044-12-03
Smart Images

Figure CN119530142A_ABST
Abstract
The invention belongs to the technical field of medicines, and particularly relates to a separation method of ovarian cancer related mesenchymal stem cells and application of the ovarian cancer related mesenchymal stem cells in tumor resistance. The separation method comprises the following steps: (S1) extracting and separating mesenchymal stem cells from a fresh tumor sample of an ovarian cancer patient by adopting a direct tissue block method; and (S2) screening and confirming that the mesenchymal stem cells are tumor-derived mesenchymal stem cells through cellular morphology identification, surface marker analysis, iterative stemness detection and tumor and / or fibroblast marker exclusion experiments in sequence. Experiments prove that the ovarian cancer related mesenchymal stem cells can be used for evaluating the anti-tumor efficacy, the anti-invasion ability supported by a tumor matrix and / or the anti-balling ability supported by the tumor matrix of drugs.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Mesenchymal stem cell for inhibiting tumor growth and preparation method and application
CN108715832A
Human cervical adenocarcinoma cell line and preparation method and application thereof
CN109929804A
Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
US20100273160A1